Chemoinformaics analysis of (+)-1,2-DIDEHYDROPINIDINOL
| Molecular Weight | 155.241 | nRot | 2 |
| Heavy Atom Molecular Weight | 138.105 | nRig | 6 |
| Exact Molecular Weight | 155.131 | nRing | 1 |
| Solubility: LogS | -1.276 | nHRing | 1 |
| Solubility: LogP | 1.748 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.2675 |
| nHD | 1 | BPOL | 18.1945 |
| QED | 0.647 |
| Synth | 4.014 |
| Natural Product Likeliness | 0.767 |
| NR-PPAR-gamma | 0.04 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.099 |
| HIA | 0.012 |
| CACO-2 | -4.282 |
| MDCK | 0.0000364 |
| BBB | 0.942 |
| PPB | 0.566288 |
| VDSS | 1.505 |
| FU | 0.485603 |
| CYP1A2-inh | 0.076 |
| CYP1A2-sub | 0.894 |
| CYP2c19-inh | 0.053 |
| CYP2c19-sub | 0.836 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.761 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.717 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.335 |
| CL | 9.748 |
| T12 | 0.685 |
| hERG | 0.033 |
| Ames | 0.015 |
| ROA | 0.065 |
| SkinSen | 0.574 |
| Carcinogencity | 0.511 |
| EI | 0.945 |
| Respiratory | 0.866 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.937014 |